We are an oncology company that is focused on the development of oncolytic viruses that are able to selectively kill cancer cells and secondarily illicit a natural immune response. SATOR Therapeutics has developed a library of 30 oncolytic viruses which have demonstrated a differential response acro...
Use this information to figure out if this company is an ideal customer for you.
1100 Cedar Ave Suite 146
Cleveland, 44106
Sator Therapeutics's CEO is Anton Komar
Sator Therapeutics's CTO is Anton Komar
Sator Therapeutics's HQ is located at 1100 Cedar Ave Suite 146, Cleveland
Sator Therapeutics's official website is satortx.com
Sator Therapeutics's revenue is $1M - $5M
Sator Therapeutics has 11 - 50 employees
Sator Therapeutics is in the industry of: Pharmaceuticals